Extensive H+ release by bone substitutes affects biocompatibility in vitro testing

Journal of Biomedical Materials Research - Part A

Volumn 76, Issue 2, 2006, Pages 310-322

  Jager M ^a   Fischer, T ^a   Schultheis, A ^a   Lensing Hohn S ^a   Krauspe, R ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Bioincompatibility; Bone marrow; Bone substitutes; in vitro; pH

Indexed keywords

BIOCOMPATIBILITY; BIOMATERIALS; BONE; CELL CULTURE; COLLAGEN; MORPHOLOGY; ORTHOPEDICS; PH; TOXICITY;

BIOINCOMPATIBILITY; BONE HEALING; BONE MARROW; BONE SUBSTITUTES; DEMINERALIZED HUMAN BONE MATRICES (DBM); IN VITRO; LASER FLOW CYTOMETRY; PHASE-CONTRAST MICROSCOPY; TRAUMA SURGERY; TRICALCIUM PHOSPHATES (TCP);

BIOMEDICAL ENGINEERING;

CALCIUM PHOSPHATE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYDROGEN;

ARTICLE; BIOCOMPATIBILITY; BONE MARROW CELL; BONE PROSTHESIS; FEMALE; FRACTURE HEALING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; ORTHOPEDIC SURGERY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE MARROW CELLS; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CATTLE; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA; HUMANS; HYDROGEN-ION CONCENTRATION; MATERIALS TESTING; PROTONS;

EID: 33644785178     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30515     Document Type: Article

References (48)

1. Stemberg F, Wilke A. Evaluation of bioresorbable polymers of lactic acid in a culture of human bone marrow cells. J Biomater Sci Polym Ed 2001;12:171-184.
2. Campoccia D, Arciola CR, Cervellati M, Maltarello MC, Montanaro L. In vitro behaviour of bone marrow-derived mesenchymal cells cultured on fluorohydroxyapatite-coated substrata with different roughness. Biomaterials 2003;24:587-596.
3. Jäger M, Wild A, Lensing-Höhn S, Krauspe R. Influence of different culture solutions on osteoblastic differentiation in cord blood and bone marrow derived progenitor cells. Biomed Tech (Berl) 2003;48:241-244.
4. Sandhu HS, Grewal HS, Parvataneni H. Bone grafting for spinal fusion. Orthop Clin North Am 1999;30:685-698.
5. Becerra J, Andrades JA, Ertl DC, Sorgente N, Nimni ME. Demineralized bone matrix mediates differentiation of bone marrow stromal cells in vitro: effect of age of cell donor. J Bone Miner Res 1996;11:1703-1714.
6. Blum B, Moseley J, Miller L, Richelsoph K, Haggard W. Measurement of bone morphogenetic proteins and other growth factors in demineralized bone matrix. Orthopedics 2004;27(Suppl 1):S161-S165.
7. Ludwig SC, Boden SD. Osteoinductive bone graft substitutes for spinal fusion: a basic science summary. Orthop Clin North Am 1999;30:635-645.
8. Ludwig SC, Kowalski JM, Boden SD. Osteoinductive bone graft substitutes. Eur Spine J 2000;9(Suppl 1):S119-S125.
9. Callan DP, Salkeld SL, Scarborough N. Histologic analysis of implant sites after grafting with demineralized bone matrix putty and sheets. Implant Dent 2000;9:36-44.
10. Lomas RJ, Gillan HL, Matthews JB, Inghamn E, Kearney JN. An evaluation of the capacity of differently prepared demineralised bone matrices (DBM) and toxic residuals of ethylene oxide (EtOx) to provoke an inflammatory response in vitro. Biomaterials 2001;22:913-921.
11. Matic D, Phillips JH. A contraindication for the use of hydroxyapatite cement in the pediatric population. Plat Reconstr Surg 2002;110:1-5.
12. Zheng D, Yang S, Li J, Xu W, Yang C, Liu Y, Pan H, Huang Z. Experimental study on allogenic decalcified bone matrix as carrier for bone tissue engineering. J Huazhong Univ Sci Technol Med Sci 2004;24:147-150.
13. Boskey AL. Osteopontin and related phosphorylated sialoproteins: effects on mineralization. Ann N Y Acad Sci 1995;760:249-256.
14. Bushinsky DA, Frick KK. The effects of acid on bone. Curr Opin Nephrol Hypertens 2000;9:369-379.
15. Meghji S, Morrison MS, Henderson B, Arnett TR. PH dependence of bone resorption: mouse calvaria osteoclasts are activated by acidosis. J Physiol Endocrinol Metab 2001;280:E112-E119.
16. Linhart W, Peters J, Lwhmann W, Schwarz K, Schilling AF, Amling M, Rueger JM, Epple M. Biological and chemically optimized composites of carbonated apatite and polyglycolide as bone substitution materials. J Biomed Mater Res 2001;54:162-171.
17. Perry CR. Bone repair techniques, bone graft and bone graft substitutes. Clin Orthop 1999;360:71-86.
18. Peterson B, Whang PG, Iglesias R, Wang JC, Lieberman JR. Osteoinductivity of commercially available demineralized bone matrix. Preparations in a spine fusion model. J Bone Joint Surg Am 2004;86-A:2243-2250.
19. Louis-Ugbo J, Murakami H, Kim HS, Minamide A, Boden SD. Evidence of osteoinduction by Grafton demineralized bone matrix in nonhuman primate spinal fusion. Spine 2004;29:360-366.
20. Bucholz RW. Nonallograft osteoconductive bone graft substitutes. Clin Orthop Relat Res 2002;395:44-52.
21. Henderson IJ, Tuy B, Connell D, Oakes B, Hettwer WH. Prospective clinical study of autologous chondrocyte implantation and correlation with MRI at three and 12 months. Bone Joint Surg Br 2003;85:1060-1066.
22. Jäger M, Wilke A. Comprehensive biocompatibility testing of a new PMMA-HA bone cement versus conventional PMMA cement in vitro. J Biomater Sci Polym Ed 2003;14:1283-1298.
23. Yadav KL, Brown PW. Formation of hydroxyapatite in water, Hank's solution, and serum at physiological temperature. J Biomed Mater Res A 2003;65:158-163.
24. Saalfeld U, Meenen NM, Jures TT, Saalfeld H. Solubility behaviour of synthetic hydroxyapatites in aqueous solution: influence of amorphous constituents on pH value. Biomaterials 1994;15:905-908.
25. Klein CP, de Blieck-Hogervorst JM, Wolke JG, de Groot K. Studies of the solubility of different calcium phosphate ceramic particles in vitro. Biomaterials 1990;11:509-512.
26. Christoffersen J, Christoffersen MR. Kinetics of dissolution of calcium hydroxyapatite IV: the effect of some biologically important inhibitors. J Crystal Growth 1981;53:31-41.
27. Klein CP, Driessen AA, de Groot K. Relationship between the degradation behaviour of calcium phosphate ceramics and their physical-chemical characteristics and ultrastructural geometry. Biomaterials 1984;5:157-160.
28. Wang H, Lee JK, Moursi A, Lannutti JJ. Ca/P ratio effects on the degradation of hydroxyapatite in vitro. J Biomed Mater Res 2003;76A:599-608.
29. Ito M, Yamagishi T, Yagasaki H, Kafrawy AH. In vitro properties of a chitosan-bonded bone-filling paste: studies on solubility of calcium phosphate compounds. J Biomed Mater Res 1996;32:95-98.
30. Tadic D, Epple M. A thorough physicochemical characterisation of 14 calcium phosphate-based bone substitution materials in comparison to natural bone. Biomaterials 2004;25:987-994.
31. Meli M, Granouillet OR, Reynaud E, Chamson A, Frey J, Perier C. Changes in glycation of fibrous type I collagen during long-term in vitro incubation with glucose. J Protein Chem 2003;22:521-525.
32. Nomura Y, Yamano M, Hayakawa C, Ishii Y, Shirai K. Structural property and in vitro self-assembly of shark type I collagen. Biosci Biotechnol Biochem 1997;61:1919-1923.
33. Ciapetti G, Stea S, Granchi D, Cavedagna D, Gamberini S, Pizzoferrato A. The effects of orthopaedic cements on osteoblastic cells cultured in vitro. Chir Organi Mov 1995;80:409-415.
34. Laquerriere P, Kilian L, Bouchot A, Jallot E, Grandjean A, Guenounou M, Balossier G, Frayssinet P, Bonhomme P. Effect of hydroxyapatite sintering temperature on intracellular ionic concentrations of monocytes: a TEM-cryo-X-ray microanalysis study. J Biomed Mater Res 2001;58:238-246.
35. Robinson D, Alk D, Sandbank J, Farber R, Halperin N. Inflammatroy reactions associated with a calcium sulfate bone substitute. Ann Transplant 1999;4:91-97.
36. Chakkalakal DA, Mashoof AA, Novak J, Strates BS, McGuire MH. Mineralization and pH relationships in healing skeletal defects grafted with demineralized bone matrix. J Biomed Mater Res 1994;28:1439-1443.
37. Takikawa S, Bauer TW, Kambic H, Togawa D. Comparative evaluation of the osteoinductivity of two formulations of human demineralized bone matrix. J Biomed Mater Res 2003;65A:37-42.
38. Bostrom MP, Yang X, Kennan M, Sandhu H, Dicarlo E, Lane JM. An unexpected outcome during testing of commercially available demineralized bone graft materials: how safe are the nonallograft components? Spine 2001;26:1425-1428.
39. Jaw R, Silveira E, Yonchek J, Kirk J, Natara C. Comparative analysis of osteoinductivity testing methods. Pittburgh Bone Symposium 20-22 Aug 2003, p 523-536.
40. Rowley SD. Hematopoietic stem cell cryopreservation: a review of current techniques. J Hematother 1992;1:233-250.
41. Walter Z, Szostek M, Weglarska D, Raguszewska D, Jablonski M, Lorenz F, Skotnicki AB. Methods for freezing, thawing and viability estimation of hemopoietic stem cells. Przegl Lek 1999;56(Suppl 1):34-39.
42. Takahashi T, Bross JB, Shaber RE, Williams RJ. Effect of cryoprotectants on the viability and function of unfrozen human polymorphonuclear cells. Cryobiology 1985;22:336-350.
43. Nath KA, Grande JP, Croatt AJ, Likely S, Hebbel RP, Enright H. Intracellular targets in heme protein-induced renal injury. Kidney Int 1998;53:100-111.
44. Chow LC, Takagi S. A natural bone cement-a laboratory novelty led to the development of revolutionary new biomaterial. J Rest Natl Inst Stand Technol 2001;106:1029-1033.
45. Driessens FCM. Formation and stability of calcium phosphates in relation to the phase composition of the mineral in calcified tissues. In: de Groot K, editors. Bioceramics of calcium phosphate. Boca Raton, FL: CRC Press; 1983. p 2-32.
46. Greish YE, Brown PW. Phase evolution during the formation of stoichiometric hydroxyapatite at 37.4 degrees C. J Biomed Mater Res B Appl Biomater 2003;67:632-637.
47. Marinucci L, Lilli C, Guerra M, Belcastro S, Becchetti, Stabellini G, Calvi EM, Locci P. Biocompatibility of collagen membranes crosslinked with glutaraldehyde or diphenylphosphoryl azide: an in vitro study. J Biomed Mater Res 2003;67A:504-509.
48. Jäger M, Feser T, Denck H, Krauspe R. Proliferation and osteogenic differentiation of mesenchymal stem cells cultured onto three different polymers in vitro. Ann Biomed Eng 2005. Forthcoming.